Matthew Farrer, PhD, Imperial College
Affiliations: | Neurogenetics and Translational Medicine | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Area:
Neurodegenerative diseasesWebsite:
http://www.cmmt.ubc.ca/research/investigators/farrer/labGoogle:
"Matthew Farrer"Mean distance: 19.3 (cluster 28)
Cross-listing: Alzheimer's Tree
Children
Sign in to add trainee| Igor Tatarnikov | grad student | 2015- | UBC (FlyTree) |
| Stefano Cataldi | grad student | 2014-2018 | UBC (FlyTree) |
| Bahareh Behrouz | post-doc | 2008-2010 | Mayo Clinic Jacksonville |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lai D, Alipanahi B, Fontanillas P, et al. (2021) Genome-wide association studies of LRRK2 modifiers of Parkinson's disease. Annals of Neurology |
| Bentley SR, Guella I, Sherman HE, et al. (2021) Hunting for Familial Parkinson's Disease Mutations in the Post Genome Era. Genes. 12 |
| Lin CH, Farrer MJ, Wu RM. (2021) Reply: UQCRC1 variants in Parkinson's disease: a large cohort study in the Chinese mainland. Brain : a Journal of Neurology |
| Kuhlmann N, Wagner Valladolid M, Quesada-Ramírez L, et al. (2021) Chronic and Acute Manipulation of Cortical Glutamate Transmission Induces Structural and Synaptic Changes in Co-cultured Striatal Neurons. Frontiers in Cellular Neuroscience. 15: 569031 |
| Bu M, Farrer MJ, Khoshbouei H. (2021) Dynamic control of the dopamine transporter in neurotransmission and homeostasis. Npj Parkinson's Disease. 7: 22 |
| Follett J, Farrer MJ. (2021) LRRK2; a dynamic regulator of cellular trafficking. Brain Research. 1761: 147394 |
| Robert J, Weilinger NL, Cao LP, et al. (2020) An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases. Molecular Neurodegeneration. 15: 70 |
| Lin CH, Tsai PI, Lin HY, et al. (2020) Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy. Brain : a Journal of Neurology |
| Lüth T, König IR, Grünewald A, et al. (2020) Age at Onset of LRRK2 p.Gly2019Ser Is Related to Environmental and Lifestyle Factors. Movement Disorders : Official Journal of the Movement Disorder Society |
| Brown EE, Blauwendraat C, Trinh J, et al. (2020) Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease. Neurobiology of Aging |